Characteristics and Outcomes of Patients with Neovascular Age-Related Macular Degeneration by Anti-VEGF Exposure in United States Clinical Practice
Open Access
- 2 July 2025
- journal article
- Published by Elsevier in Ophthalmology Retina
- Vol. 10 (1) , 71-80
Abstract
No abstract availableKeywords
Funding Information
- Regeneron Pharmaceuticals Inc
This publication has 12 references indexed in Scilit:
- Visual Acuity Outcomes in Patients Receiving Frequent Treatment of Neovascular Age-Related Macular Degeneration in Clinical PracticeJournal of Vitreoretinal Diseases, 2020
- Management and Outcomes for Neovascular Age-Related Macular DegenerationOphthalmology, 2020
- Demographic and Clinical Factors that Influence the Visual Response to Anti-Vascular Endothelial Growth Factor Therapy in Patients with Neovascular Age-Related Macular Degeneration: A Systematic ReviewOphthalmology and Therapy, 2020
- Visual Acuity Outcomes and Anti–Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration PatientsOphthalmology Retina, 2020
- Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatmentScientific Reports, 2019
- Racial Differences in Age-Related Macular Degeneration and Associated Anti–Vascular Endothelial Growth Factor Intravitreal Injections among Medicare BeneficiariesOphthalmology Retina, 2018
- Real-world Outcomes of Anti–Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration in the United StatesOphthalmology Retina, 2018
- CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICERetina, 2015
- Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degenerationBritish Journal of Ophthalmology, 2014
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZONOphthalmology, 2013